Modulus Therapeutics
This company is dedicated to using machine learning to design cell therapies to treat more diseases and patients than ever before.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD22—32m (Dealroom.co estimates Jul 2021.)
Seattle Washington (HQ)
Authorizing premium user...